Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study.
Kelly DL, Gorelick DA, Conley RR, Boggs DL, Linthicum J, Liu F, Feldman S, Ball MP, Wehring HJ, McMahon RP, Huestis MA, Heishman SJ, Warren KR, Buchanan RW. Kelly DL, et al. Among authors: huestis ma. J Clin Psychopharmacol. 2011 Feb;31(1):86-91. doi: 10.1097/JCP.0b013e318204825b. J Clin Psychopharmacol. 2011. PMID: 21192149 Free PMC article. Clinical Trial.
Antagonist-elicited cannabis withdrawal in humans.
Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, McMahon RP, Liu F, Ortemann-Renon C, Bonnet D, Huestis MA. Gorelick DA, et al. Among authors: huestis ma. J Clin Psychopharmacol. 2011 Oct;31(5):603-12. doi: 10.1097/JCP.0b013e31822befc1. J Clin Psychopharmacol. 2011. PMID: 21869692 Free PMC article. Clinical Trial.
Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study.
Warren KR, Buchanan RW, Feldman S, Conley RR, Linthicum J, Ball MP, Liu F, McMahon RP, Gorelick DA, Huestis MA, Kelly DL. Warren KR, et al. Among authors: huestis ma. J Clin Psychopharmacol. 2013 Feb;33(1):118-20. doi: 10.1097/JCP.0b013e3182793843. J Clin Psychopharmacol. 2013. PMID: 23277241 Free PMC article. Clinical Trial. No abstract available.
CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men.
Goodwin RS, Baumann MH, Gorelick DA, Schwilke E, Schwope DM, Darwin WD, Kelly DL, Schroeder JR, Ortemann-Renon C, Bonnet D, Huestis MA. Goodwin RS, et al. Among authors: huestis ma. Am J Drug Alcohol Abuse. 2012 Jan;38(1):114-9. doi: 10.3109/00952990.2011.600398. Epub 2011 Jul 29. Am J Drug Alcohol Abuse. 2012. PMID: 21797816 Free PMC article. Clinical Trial.
Psychiatric symptom differences in people with schizophrenia associated with substantial lifetime substance use but no current substance use disorder.
Koola MM, Gorelick DA, McMahon RP, Liu F, Huestis MA, Linthicum J, Feldman SM, Warren KR, Wehring HJ, Kelly DL. Koola MM, et al. Among authors: huestis ma. Schizophr Res. 2014 Jan;152(1):315-6. doi: 10.1016/j.schres.2013.11.035. Epub 2013 Dec 12. Schizophr Res. 2014. PMID: 24333005 Free PMC article. No abstract available.
537 results